Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Amy E. Armstrong"'
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-12 (2023)
Abstract Neurofibromatosis type 1 (NF1), the most common tumor predisposition syndrome, occurs when NF1 gene variants result in loss of neurofibromin, a negative regulator of RAS activity. Plexiform neurofibromas (PN) are peripheral nerve sheath tumo
Externí odkaz:
https://doaj.org/article/e7e7711405894d27acfa73a6504142c7
Autor:
Amit Sharma, Amy E. Armstrong
Publikováno v:
Case Reports in Medicine, Vol 2012 (2012)
Introduction. Giant cell tumor of the bone is a rare benign lesion that infrequently affects the ribs, and if present, is usually located posteriorly. The rarity of this tumor poses diagnostic and therapeutic problems for physicians, especially when
Externí odkaz:
https://doaj.org/article/0d68dcf60a7d4cb983dcd92860dfa57e
Autor:
Michael V. Ortiz, Christa Koenig, Amy E. Armstrong, Jesper Brok, Beatriz de Camargo, Annelies M. C. Mavinkurve‐Groothuis, Thelma B. Velasquez Herrera, Rajkumar Venkatramani, Andrew D. Woods, Jeffrey S. Dome, Filippo Spreafico
Publikováno v:
Pediatric Blood & Cancer. 70
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f06bc5ed06825f5a94116651de28139e
https://doi.org/10.1002/pbc.30342
https://doi.org/10.1002/pbc.30342
Autor:
Irem Eldem, Jennifer Picarsic, Ashish Kumar, Yaël P. Mossé, Kaleigh Filisa Roberts, Amy E. Armstrong, Bryan A. Sisk
Publikováno v:
Pediatric Blood & Cancer.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a6a44cfcbd511c06cba52444e8db1784
https://doi.org/10.1002/pbc.30378
https://doi.org/10.1002/pbc.30378
Autor:
Ami V Desai, Giles W Robinson, Karen Gauvain, Ellen M Basu, Margaret E Macy, Luke Maese, Nicholas S Whipple, Amit J Sabnis, Jennifer H Foster, Suzanne Shusterman, Janet Yoon, Brian D Weiss, Mohamed S Abdelbaki, Amy E Armstrong, Thomas Cash, Christine A Pratilas, Nadège Corradini, Lynley V Marshall, Mufiza Farid-Kapadia, Saibah Chohan, Clare Devlin, Georgina Meneses-Lorente, Alison Cardenas, Katherine E Hutchinson, Guillaume Bergthold, Hubert Caron, Edna Chow Maneval, Amar Gajjar, Elizabeth Fox
Publikováno v:
Neuro-Oncology. 24:1776-1789
Background Entrectinib is a TRKA/B/C, ROS1, ALK tyrosine kinase inhibitor approved for the treatment of adults and children aged ≥12 years with NTRK fusion-positive solid tumors and adults with ROS1 fusion-positive non–small-cell lung cancer. We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03639f7f0384b3824fab7613aeb1e8fa
https://doi.org/10.1093/neuonc/noac087
https://doi.org/10.1093/neuonc/noac087
Autor:
Amy E Armstrong, Samantha Gadd, Vicki Huff, Daniela S Gerhard, Jeffrey S Dome, Elizabeth J Perlman
Publikováno v:
PLoS ONE, Vol 13, Iss 12, p e0208936 (2018)
This study explores the genomic alterations that contribute to the formation of a unique subset of low-risk, epithelial differentiated, favorable histology Wilms tumors (WT), tumors that have been characterized by their expression of post-induction r
Externí odkaz:
https://doaj.org/article/b4297202c4ee46a484b18f0b7575a015
Autor:
Dana Sous, Amy E. Armstrong, Sonal Shah, Valerie M. Carlberg, Jennifer T. Huang, Carrie C. Coughlin
Publikováno v:
Pediatric Dermatology. 38:8-17
Chemotherapies often cause side effects of the skin, nails, and mucosal surfaces. These mucocutaneous toxicities contribute to morbidity and affect quality of life. Identification and management of these drug-induced eruptions is vital to allow for c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b35189bac706cfe7fbf3a5e0f1d93e01
https://doi.org/10.1111/pde.14418
https://doi.org/10.1111/pde.14418
Autor:
Jason Karpus, Sakshi Uppal, Lucy A. Godley, Zhou Zhang, Amy E. Armstrong, Susan L. Cohn, Wei Zhang, Erin K. Barr, Barbara E. Stranger, Emma Wilkinson, Chuan He, Robert L. Grossman, Madina Sukhanova, Helen R. Salwen, Alexandre Chlenski, Mark A. Applebaum, Marija Dobratic, Ji Nie
Publikováno v:
JCO precision oncology
PURPOSE Whole-genome profiles of the epigenetic modification 5-hydroxymethylcytosine (5-hmC) are robust diagnostic biomarkers in adult patients with cancer. We investigated if 5-hmC profiles would serve as novel prognostic markers in neuroblastoma, a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ea35b284bf4dc6448bd043e1db86c2c
https://doi.org/10.1200/po.18.00402
https://doi.org/10.1200/po.18.00402
Publikováno v:
Expert opinion on investigational drugs. 31(1)
Neurofibromatosis Type 1 (NF1) is an autosomal dominant genetic condition, which predisposes individuals to the development of plexiform neurofibromas (PN), benign nerve sheath tumors seen in 30-50% of patients with NF1. These tumors may cause signif
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd7509664defade8d2cacd137ac1cf3e
https://pubmed.ncbi.nlm.nih.gov/34932916
https://pubmed.ncbi.nlm.nih.gov/34932916
Autor:
Margaret Shatara, Evan Cantor, Ashley Meyer, Andrea Ogle, Kimberly Hofmann, Tammy Green, Mary Beck, Michele McHugh, Nicole Brossier, Andrew Cluster, Ali Mian, Sonika Dahiya, Zeyad M Abdelaziz, Shady Fadel, Nahla Mobark, Musa AlHarbi, Soad AlJaouni, Abrar Aljunaid, Waleed Said, Moatasem El-ayadi, Madeha Mahmoud, Abeer Al-Battashi, Imène Chabchoub, Nisreen Khalifa, Nora Dengler, Pablo Hernáiz Driever, Nicolás Rojas Del Río, Bozenna Dembowska-Bagińska, Marta Perek-Polnik, Szymon Skoczeń, Hetal Dholaria, Sumanth Nagabushan, Milena Oliveira, Angela C Hirbe, Amy E Armstrong, David Limbrick, David H Gutmann, Mohamed S Abdelbaki
Publikováno v:
Neuro-Oncology. 24:i163-i164
BACKGROUND: The management of childhood central nervous system (CNS) tumors is complex and often faces numerous challenges in low- and middle- income countries (LMICs), including delayed diagnosis and limited treatment resources. Twinning initiatives
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d29d77736eb62ac083a235360b60ea7e
https://doi.org/10.1093/neuonc/noac079.607
https://doi.org/10.1093/neuonc/noac079.607